Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-19

Clinical Trial Update: Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement [Phase 3]

View source ↗

Summary

Phase 3 trial investigates the effect of oral pregabalin on spinal neurotransmitters in patients undergoing knee replacement; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Asokumar Buvanendran | Conditions: PAIN | Phase 3 | Status: COMPLETED | Results posted: 2012-12-19